Firdaus J. Dastoor
CIK: 0001690576
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XBIO
Xenetic Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Dastoor Firdaus J.
Dastoor Firdaus J. (SEC CIK 0001690576) files insider reports with the SEC as Director of Xenetic Biosciences, Inc. (XBIO).
Signal8 holds 2 ownership filings by Dastoor Firdaus J., all Form 4s, filed between Dec 13, 2024 and Jan 5, 2026. Those filings report 2 transactions, from Dec 11, 2024 to Dec 31, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Dastoor Firdaus J.'s filings is in FRAMINGHAM, MA.
Recent filings by Dastoor Firdaus J.
Other insiders filing for Xenetic Biosciences, Inc. (XBIO)
- PARSLOW JAMES F, Interim CEO and CFO
- VINOGRADOV ALEXEY ANDREEVICH, Director
- Kornberg Roger D., Director
- Borisenko Grigory G., Director